JP2024521098A5 - - Google Patents
Info
- Publication number
- JP2024521098A5 JP2024521098A5 JP2023571758A JP2023571758A JP2024521098A5 JP 2024521098 A5 JP2024521098 A5 JP 2024521098A5 JP 2023571758 A JP2023571758 A JP 2023571758A JP 2023571758 A JP2023571758 A JP 2023571758A JP 2024521098 A5 JP2024521098 A5 JP 2024521098A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- amino acid
- acid sequence
- seq
- sequence described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163190964P | 2021-05-20 | 2021-05-20 | |
| US63/190,964 | 2021-05-20 | ||
| US202263341771P | 2022-05-13 | 2022-05-13 | |
| US63/341,771 | 2022-05-13 | ||
| PCT/US2022/030068 WO2022246084A1 (en) | 2021-05-20 | 2022-05-19 | Sars-cov-2 polypeptides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024521098A JP2024521098A (ja) | 2024-05-28 |
| JP2024521098A5 true JP2024521098A5 (enExample) | 2025-05-28 |
Family
ID=82321637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571758A Pending JP2024521098A (ja) | 2021-05-20 | 2022-05-19 | ＳＡＲＳ－ＣｏＶ－２ポリペプチド |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220370601A1 (enExample) |
| EP (1) | EP4294440A1 (enExample) |
| JP (1) | JP2024521098A (enExample) |
| KR (1) | KR20240012394A (enExample) |
| AU (1) | AU2022277697A1 (enExample) |
| BR (1) | BR112023024034A2 (enExample) |
| CA (1) | CA3212678A1 (enExample) |
| IL (1) | IL308465A (enExample) |
| MX (1) | MX2023013665A (enExample) |
| WO (1) | WO2022246084A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024006362A1 (en) * | 2022-06-28 | 2024-01-04 | Transcode Therapeutics, Inc. | Nanoparticles and template directed rig-i agonist precursor compositions and uses thereof for cancer therapy |
| CN115947801B (zh) * | 2022-12-29 | 2026-02-06 | 中国疾病预防控制中心病毒病预防控制所 | 一种流感病毒通用和冠状病毒联合多肽及其疫苗的应用 |
| CN116143908A (zh) * | 2023-02-10 | 2023-05-23 | 武汉华美生物工程有限公司 | 一种针对VLPs类型抗原免疫产生高效价抗血清的方法 |
| WO2025231068A1 (en) * | 2024-04-30 | 2025-11-06 | The Regents Of The University Of Michigan | Compositions and methods for enhancing systemic and mucosal immune responses |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250107297A (ko) * | 2020-04-02 | 2025-07-11 | 리제너론 파아마슈티컬스, 인크. | 항-sars-cov-2 스파이크 당단백질 항체 및 항원-결합 단편 |
| EP4132576A1 (en) * | 2020-04-09 | 2023-02-15 | Suzhou Abogen Biosciences Co., Ltd. | Nucleic acid vaccines for coronavirus |
| US20230143215A1 (en) * | 2020-04-23 | 2023-05-11 | Isa Pharmaceuticals B.V. | Immunization against sars-cov-related diseases |
| GB202011652D0 (en) * | 2020-07-28 | 2020-09-09 | Univ Oxford Innovation Ltd | Polypeptide panels and uses thereof |
| US11191827B1 (en) * | 2020-12-09 | 2021-12-07 | Tevogen Bio Inc. | COVID-19 peptide specific T-cells and methods of treating and preventing COVID-19 |
-
2022
- 2022-05-19 WO PCT/US2022/030068 patent/WO2022246084A1/en not_active Ceased
- 2022-05-19 AU AU2022277697A patent/AU2022277697A1/en active Pending
- 2022-05-19 CA CA3212678A patent/CA3212678A1/en active Pending
- 2022-05-19 IL IL308465A patent/IL308465A/en unknown
- 2022-05-19 EP EP22735677.1A patent/EP4294440A1/en active Pending
- 2022-05-19 US US17/748,715 patent/US20220370601A1/en active Pending
- 2022-05-19 BR BR112023024034A patent/BR112023024034A2/pt unknown
- 2022-05-19 MX MX2023013665A patent/MX2023013665A/es unknown
- 2022-05-19 KR KR1020237039921A patent/KR20240012394A/ko active Pending
- 2022-05-19 JP JP2023571758A patent/JP2024521098A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024521098A5 (enExample) | ||
| CN113666990B (zh) | 一种诱导广谱抗冠状病毒的t细胞疫苗免疫原及其应用 | |
| US20240370011A1 (en) | Compositions and methods of ribonucleic acid respiratory syncytial virus (rsv) vaccines | |
| CN111108192A (zh) | 非人类人猿腺病毒核酸序列和氨基酸序列、含有其的载体及其用途 | |
| JP2020530765A5 (enExample) | ||
| WO2022135563A1 (zh) | 同时诱导抗多种病毒的免疫应答的方法 | |
| WO2022010813A2 (en) | Enhancing immune responses through targeted antigen expression | |
| TWI901715B (zh) | 大猩猩腺病毒核酸及胺基酸序列，包含彼之載體，及其用途 | |
| JP2025084850A (ja) | ハンタウイルス抗原性組成物 | |
| JP2023529124A (ja) | コロナウイルスワクチンコンストラクトおよびこれを作製し使用する方法 | |
| JP4797149B2 (ja) | インフルエンザウイルスに対するベクターワクチン | |
| CN110229219A (zh) | 一种新型的呼吸道合胞病毒疫苗抗原的制备方法及其用途 | |
| JP2024523329A5 (enExample) | ||
| WO2022171182A1 (zh) | 一种治疗或者预防冠状病毒病突变株的疫苗试剂 | |
| CN112135908A (zh) | 选择性cd8阳性t细胞诱导疫苗抗原 | |
| US20230201330A1 (en) | Virus-like particles containing RSV antigen protein and vaccines using the same | |
| JP2002510496A (ja) | 細胞傷害性ｔ細胞を誘導するための医薬 | |
| WO2025075129A1 (ja) | コロナウイルススパイクタンパク質変異体 | |
| US9060973B2 (en) | Vaccine for enveloped viruses | |
| CN119264229A (zh) | 基于SARS-CoV-2的不同奥密克戎变异型的S蛋白的疫苗和组合物 | |
| WO2025260633A1 (zh) | Rsv和hmpv融合f蛋白及其用途 | |
| CN118792321A (zh) | 牛纽布病毒病毒样颗粒、制备方法及应用 | |
| WO2022195900A1 (ja) | 組換え麻疹ウイルス | |
| CN116457011A (zh) | 用于治疗冠状病毒的疫苗组合物 | |
| JP2024525578A5 (enExample) |